Metabolic [ftcn]
IMPACT [gngm]
ADD [mobd]
medroxyprogesterone acetate [horm, phsu, strd]
Conjugated [spco]
estrogen therapy [topp]
postmenopausal [tmco]
Women [popg]
Objective [inpr]
Evaluate [ftcn]
IMPACT [gngm]
Dosages [qnco]
medroxyprogesterone acetate [horm, phsu, strd]
Metabolism [orgf]
Haemostasis [ortf]
postmenopausal [tmco]
Women [popg]
treated [topp]
Estrogens, Conjugated [horm, phsu, strd]
Methods [inpr]
prospective [resa]
Double-Blind Study [resa]
Women [popg]
randomized [resa]
Five [qnco]
treatment [ftcn]
Group [idcn]
Sites [spco]
United States [geoa]
Europe [geoa]
participants [popg]
Received [qlco]
mg% [qnco]
Estrogens, Conjugated [horm, phsu, strd]
Daily [tmco]
Cycle [tmco]
Group [idcn]
Received [qlco]
medroxyprogesterone acetate [horm, phsu, strd]
mg day [qnco]
mg day [qnco]
Last [qlco]
days [tmco]
Cycle [tmco]
effects [qlco]
Lipid [lipd]
Carbohydrate Metabolism [moft]
Coagulation [ortf]
Evaluated [ftcn]
plasma lipid [lbpr]
Occurred [acty]
Group [idcn]
Greatest [qnco]
Estrogens, Conjugated [horm, phsu, strd]
Alone [qnco]
P NOS [aapp, imft]
Equal To [qlco]
Fasting [fndg]
Glucose [bacs, carb, phsu]
insulin levels [lbpr]
Insulin [aapp, horm, phsu]
Response [orga]
Glucose [bacs, carb, phsu]
Challenge [clna]
Blunted [qlco]
Group [idcn]
P NOS [aapp, imft]
Equal To [qlco]
Clinical Significance [fndg]
Occurred [acty]
haemostatic [ortf]
Levels [qlco]
Conclusions [idcn]
Metabolic [ftcn]
Levels [qlco]
Affected [ftcn]
Addition [ftcn]
medroxyprogesterone acetate [horm, phsu, strd]
Estrogens, Conjugated [horm, phsu, strd]
Estrogens, Conjugated [horm, phsu, strd]
Alone [qnco]
haemostatic [ortf]
Levels [qlco]
Affected [ftcn]
